Commvault Systems, Inc. faces securities fraud allegations after it failed to achieve projected net new ARR growth due to the ARR mix shift it was experiencing, leading to a stock drop of 31%; ...
How many times have you been asked to submit sensitive information, like a pay stub or tax return? Here's why you should be ...
In line with the U.S. Army’s Communications Security (COMSEC) modernization effort, the division is moving away from decades-old practices of physically loading electronic “keys” — the essential data ...
Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Commvault Systems, Inc. between April 29, 2025 and January 26, 2026, ...
Commvault Systems, Inc. faces securities fraud allegations after it failed to achieve projected net new ARR growth due to the ARR mix shift it was experiencing, leading to a stock drop of 31%; ...
RBC Capital analyst Matthew Hedberg maintained a Buy rating on F5, Inc. yesterday and set a price target of $425.00. The company’s shares closed yesterday at $379.74. Claim 55% ...
Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Commvault Systems, Inc. securities between April 29, 2025 and January 26, ...
WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Commvault Systems, Inc. (NASDAQ: CVLT) between April 29, 2025 and ...
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Commvault Systems, Inc. (“Commvault” ...
Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the ...
Storm-2949 turned stolen credentials into a cloud-wide breach, moving from identity compromise to large-scale data theft ...
Recent European hospital incidents, NIS2 accountability, EPR exposure, supplier concentration, and 72-hour downtime weakness are pushing buyers toward clinical-continuity cybersecurity ahead of HIMSS2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results